Lakefront Biotherapeutics (LKFT) EPS (Basic) (2014 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly EPS (Basic) of $0.26 for Q1 2026, up 110.51% year-over-year from $0.12 in Q1 2025, and down 98.14% quarter-over-quarter from $13.82 in Q4 2025.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) EPS (Basic) (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported EPS (Basic) for 13 consecutive years, with $0.26 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 110.51% year-over-year to $0.26; the TTM figure through Mar 2026 stood at $8.67 (up 417.42% YoY), while the FY2025 annual figure was $5.67, up 371.84% from the prior year.
- EPS (Basic) fell to $0.26 in Q1 2026 per LKFT's latest filing, from $13.82 in the prior quarter.
- Across five years, EPS (Basic) topped out at $13.82 in Q4 2025 and bottomed at -$3.59 in Q3 2025.
- Historically, EPS (Basic) has averaged $0.44 across 5 years, with a median of $0.15 in 2024.
- On a YoY basis, EPS (Basic) climbed as much as 3266.69% in 2025 and fell as far as 1337.22% in 2025.
- Lakefront Biotherapeutics' EPS (Basic) stood at -$3.22 in 2022, then jumped by 179.97% to $2.57 in 2023, then sank by 84.05% to $0.41 in 2024, then surged by 3266.69% to $13.82 in 2025, then tumbled by 98.14% to $0.26 in 2026.
- Business Quant data shows LKFT's EPS (Basic) at $0.26 in Q1 2026, $13.82 in Q4 2025, and -$3.59 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Lakefront Biotherapeutics | 1.88 Bn | 1.88 Bn | 3.51 Mn | -0.76 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.76 |
| Mar 31, 2026 | 0.26 |
| Dec 31, 2025 | 5,676.43 |
| Sep 30, 2025 | -8.84 |
| Jun 30, 2025 | 2.67 |
| Mar 31, 2025 | -2.45 |
| Dec 31, 2024 | 1,200.53 |
| Sep 30, 2024 | -1.62 |
| Jun 30, 2024 | 0.87 |
| Mar 31, 2024 | 1.49 |
| Dec 31, 2023 | 3,456.30 |
| Sep 30, 2023 | -0.54 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 3.55 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | -0.31 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.96 |
| Sep 30, 2021 | -2.79 |